Pivotal bioVenture Partners Investment Advisor LLC logo

Pivotal bioVenture Partners Investment Advisor LLC

RIA/Wealth

Pivotal bioVenture Partners Investment Advisor LLC is a RIA/Wealth based in New York, NY led by Tiffany Catherine Mcghee, reporting $420.5M in AUM as of Q3 2025 with 88% Healthcare concentration, with only 10 positions, and 29% allocation to PCVX.

CEOTiffany Catherine Mcghee
Portfolio Value
$173.0M
Positions
10
Top Holding
PCVX at 28.58%
Last Reported
Q3 2025
Address45 Rockefeller Plaza, 20th Floor, New York, NY, 10111, United States

Top Holdings

Largest long holdings in Pivotal bioVenture Partners Investment Advisor LLC's portfolio (100% of total portfolio)

See all holdings
HoldingSectorPositionWeightTradedOwnership
Biotechnology
Healthcare
$49.4M
28.58%
+$2.4M
Bought
1.06%
1.4M shares
Biotechnology
Healthcare
$40.4M
23.38%
4.40%
2.3M shares
Biotechnology
Healthcare
$40.0M
23.11%
1.77%
2.1M shares
Unknown
Unknown
$17.3M
10.00%
779.0K shares
Biotechnology
Healthcare
$11.5M
6.65%
+$1.0M
Bought
1.03%
1.3M shares
Biotechnology
Healthcare
$5.9M
3.40%
+$5.9M
New
0.58%
502.5K shares
Unknown
Unknown
$3.8M
2.22%
1.82%
653.4K shares
Biotechnology
Healthcare
$2.9M
1.68%
0.14%
595.5K shares
Biotechnology
Healthcare
$1.2M
0.69%
5.75%
2.4M shares
Biotechnology
Healthcare
$503.1K
0.29%
4.93%
94.6K shares

Changes

Portfolio activity, position movements, and quarter-over-quarter changes in Pivotal bioVenture Partners Investment Advisor LLC's latest filing

See all changes
Market Value
$173.0M
Prior: $161.3M
Q/Q Change
+7.21%
+$11.6M
Net Flows % of MV
-8.28%
Turnover Ratio
9.53%
New Purchases
1 stocks
$5.9M
Added To
2 stocks
+$3.4M
Sold Out Of
3 stocks
$23.6M
Reduced Holdings
0 stocks
--

Increased Positions

PositionShares Δ
New
+9.66%
+5.16%

Decreased Positions

PositionShares Δ
Sold
Sold
Sold

Analytics

Portfolio insights and performance metrics for Pivotal bioVenture Partners Investment Advisor LLC

View analytics

Sector Allocation

Healthcare: 87.80%Healthcare
Healthcare
87.80%

Market Cap Distribution

Mid Cap ($2B - $10B): 53.36%Mid Cap ($2B - $10B)Small Cap ($300M - $2B): 33.43%Small Cap ($300M - $2B)Micro Cap ($50M - $300M): 2.22%Nano Cap (< $50M): 10.98%Nano Cap (< $50M)
Mid Cap ($2B - $10B)
53.36%
Small Cap ($300M - $2B)
33.43%
Micro Cap ($50M - $300M)
2.22%
Nano Cap (< $50M)
10.98%

Portfolio Concentration

Top 10 Holdings %
100.0%
Top 20 Holdings %
100.0%
Top 50 Holdings %
100.0%
Top 100 Holdings %
100.0%

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.